Lipofection of cultured mouse muscle cells: A direct comparison of Lipofectamine and DOSPER

Gene Therapy

Volumn 5, Issue 4, 1998, Pages 542-551

  Dodds, E ^a   Dunckley, M G ^b   Naujoks, K ^b   Michaelis, U ^b   Dickson, G ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Gene transfer; Lipofection; Lipoplex; Skeletal muscle

Indexed keywords

BETA GALACTOSIDASE; DOSPER; GREEN FLUORESCENT PROTEIN; LIPID; LIPOFECTAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ESCHERICHIA COLI; GENE TRANSFER; MOUSE; MUSCLE CELL; MUSCLE FIBRIL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE;

ANIMALIA; BOVINAE; ESCHERICHIA COLI; MURINAE;

EID: 0031917023     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300604     Document Type: Article

References (32)

1. Dickson G, Brown SC. Duchenne muscular dystrophy. In: Dickson G (ed). Molecular and Cell Biology of Human Gene Therapeutics. Chapman and Hall: London, 1995, pp 261-280.
2. Davis H, Michel M, Whalen RG. DNA based immunisation for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Mol Genet 1993; 2: 1847-1851.
3. Bohl D, Naffakh N, Heard JM. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nature Med 1997; 3: 299-305
4. Schofield JP, Caskey CT. Non viral approaches to gene therapy. Br Med Bull 1995; 51: 56-71.
5. Zhou XH, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine - characterization and mechanism of action. Biochim Biophys Acta 1994; 1189: 195-203.
6. Nabel EG et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localisation. Hum Gene Ther 1992; 3: 649-656.
7. San H et al. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther 1993; 4: 781-788.
8. Felgner PL, Ringold GM. Cationic liposome-mediated transfection. Nature 1989; 337: 387-388.
9. Felgner PL. Lipofection: a highly efficient, lipid-mediated DNA transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7417.
10. Gao X, Huang L. A novel cationic liposome reagent for efficient transfection in mammalian cells. Biochim Biophys Res Commun 1991; 179: 280-285.
11. Jarnagin WR. Cationic lipid-mediated transfection of liver cells in primary culture. Nucleic Acids Res 1992; 20: 4205-4211.
12. Legendre JY, Szoka FC. Delivery of plasmid DNA into mammalian-cell lines using pH-sensitive liposomes - comparison with cationic liposomes. Pharma Res 1992; 9: 1235-1242.
13. Plautz GE et al. Immunotherapy of malignancy by in vivo gene transfer into tumours. Proc Natl Acad Sci USA 1993; 90: 4645-4649.
14. Stephan DJ et al. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996; 7: 1803-1812.
15. Lui Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol 1997; 15: 167-173.
16. Nabel GL et al. Direct gene transfer with DNA liposome complexes in melanoma: expression, biological activity, lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90: 11307-11311.
17. Porteous DJ et al. Evidence for safety and efficacy of DOTAP cationic liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4: 210-218.
18. Wolff JA et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 260: 926-932
19. Gregoriadis G, Saffie R, Brian de Souza J. Liposome-mediated DNA vaccination. FEBS Lett 1997; 402: 107-110.
20. Ciccarone V, Hawley-Nelson P, Gebeyehu G, Jessee J. Cationic lipid-mediated transfection of eukaryotic cells: high efficiency nucleic acid delivery with Lipofectin and Lipofectamine reagents. FASEB J 1993; 7: 454.
21. Trivedi RA, Dickson G. Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. J Neurochem 1995; 64: 2230-2238.
22. Vitiello L et al. Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. Gene Therapy 1996; 3: 396-404.
23. Chalfie M et al. GFP as a marker for gene expression. Science 1996; 263: 802-805.
24. Farhood H, Bottega R, Epand RM, Huang L. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity. Biochim Biophys Acta 1992; 1111: 239-246.
25. Staggs DR, Burton DW, Deftos LJ. Importance of liposome complexing volume in transfection optimisation. Biotechniques 1997; 21: 792-798.
26. Partridge T, Davies KE. Myoblast based gene therapies. Br Med Bull 1995; 51: 123-137.
27. Fasbender A et al. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 1997; 272: 6479-6489.
28. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270: 725-727.
29. Yasmin R et al. A quantitative technique for growing human adult skeletal muscle in culture starting fron mononucleated cells. J Neurol Sci 1977; 32: 347-360.
30. Zolotukhin S et al. A 'humanised' green fluorescent protein cDNA adapted for high level expression in mammalian cells. J Virol 1996; 70: 4646-4654.
31. Heim R, Cubitt AB, Tsien RY. Improved green fluorescence. Nature 1995; 373: 663-664.
32. Felgner PL et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther 1997; 8: 511-512.